Pheon Therapeutics Expands Board with Appointment of Dr. Enoch Kariuki
09 Sep 2024 //
PR NEWSWIRE
Pheon Announces $120M Series B For Differentiated ADC Pipeline
21 May 2024 //
PR NEWSWIRE
Pheon rides wave of ADC interest with $120M financing
20 May 2024 //
BIOPHARMADIVE
Pheon Appoints Industry Veteran Cyrus Mozayeni, MD as Chief Executive Officer
25 Jul 2023 //
PR NEWSWIRE
Pheon Therapeutics enters into license agreement with Biocytogen Pharmaceuticals
05 Jul 2023 //
PR NEWSWIRE